Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mediator kinase module (CKM), primarily consisting of CDK8 or CDK19 along with MED12, MED13, and Cyclin C, is a key regulator of RNA polymerase II activity and gene expression. It integrates extracellular signals, including those from the Wnt pathway, to modulate transcriptional responses. It phosphorylates various targets to fine-tune gene expression, making it a potential therapeutic target in cancers like colorectal carcinoma driven by aberrant Wnt signaling.
Phosphorylation of transcription factors, RNA polymerase II, and chromatin modifiers to regulate gene expression downstream of Wnt signaling and other pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator Kinase Module (CKM).